company background image
ALTHE logo

Theraclion ENXTPA:ALTHE Stock Report

Last Price

€0.33

Market Cap

€15.3m

7D

-13.3%

1Y

-7.5%

Updated

22 Dec, 2024

Data

Company Financials

My Notes

Capture your thoughts, links and company narrative

Theraclion SA Competitors

Price History & Performance

Summary of share price highs, lows and changes for Theraclion
Historical stock prices
Current Share Price€0.33
52 Week High€0.68
52 Week Low€0.29
Beta0.025
1 Month Change-9.29%
3 Month Change-13.54%
1 Year Change-7.52%
3 Year Change-72.67%
5 Year Change-79.12%
Change since IPO-97.48%

Recent News & Updates

We Think Theraclion (EPA:ALTHE) Has A Fair Chunk Of Debt

Nov 20
We Think Theraclion (EPA:ALTHE) Has A Fair Chunk Of Debt

Recent updates

We Think Theraclion (EPA:ALTHE) Has A Fair Chunk Of Debt

Nov 20
We Think Theraclion (EPA:ALTHE) Has A Fair Chunk Of Debt

Does Theraclion (EPA:ALTHE) Have A Healthy Balance Sheet?

Nov 26
Does Theraclion (EPA:ALTHE) Have A Healthy Balance Sheet?

Shareholder Returns

ALTHEFR Medical EquipmentFR Market
7D-13.3%0.003%-1.7%
1Y-7.5%23.6%-4.8%

Return vs Industry: ALTHE underperformed the French Medical Equipment industry which returned 23.6% over the past year.

Return vs Market: ALTHE underperformed the French Market which returned -4.8% over the past year.

Price Volatility

Is ALTHE's price volatile compared to industry and market?
ALTHE volatility
ALTHE Average Weekly Movement8.5%
Medical Equipment Industry Average Movement6.7%
Market Average Movement4.5%
10% most volatile stocks in FR Market9.7%
10% least volatile stocks in FR Market2.3%

Stable Share Price: ALTHE's share price has been volatile over the past 3 months compared to the French market.

Volatility Over Time: ALTHE's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of French stocks.

About the Company

FoundedEmployeesCEOWebsite
200428Martin Deterrewww.theraclion.com

Theraclion SA designs and markets high-tech therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient’s skin and optimizes the image quality. Theraclion SA was incorporated in 2004 and is based in Malakoff, France.

Theraclion SA Fundamentals Summary

How do Theraclion's earnings and revenue compare to its market cap?
ALTHE fundamental statistics
Market cap€15.28m
Earnings (TTM)-€3.56m
Revenue (TTM)€1.28m

11.9x

P/S Ratio

-4.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALTHE income statement (TTM)
Revenue€1.28m
Cost of Revenue€3.07m
Gross Profit-€1.78m
Other Expenses€1.78m
Earnings-€3.56m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.077
Gross Margin-139.01%
Net Profit Margin-277.68%
Debt/Equity Ratio240.9%

How did ALTHE perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:39
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Theraclion SA is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Fanny MeindreCIC Market Solutions (ESN)
Fanny MeindreCIC Market Solutions (ESN)
Martial DescouturesInvest Securities